Metropolis Healthcare has acquired Ambika Pathology Laboratory, founded by Rajendra Patil in 1995, marking its fourth acquisition in the past 10 months. The deal value remains undisclosed. Located in Kolhapur, Ambika operates a central laboratory supported by 12 patient touchpoints and is well known across Kolhapur and neighbouring towns for its wide range of diagnostic tests. Nearly 75% of its revenue comes from walk-in patients, underscoring its strong local connect.
This acquisition aligns with Metropolis’ “string of pearls” strategy, which aims to build regional clusters and expand access to advanced diagnostic services across India. The addition of Ambika Pathology strengthens Metropolis’ western Maharashtra cluster, where the company already operates 19 laboratories across Pune, Kolhapur, Sangli, Satara, Solapur, Nashik and Ahmednagar, supported by over 200 patient service centres and a growing franchise network.
“Maharashtra continues to be a key growth market for Metropolis, contributing nearly 40 per cent of our total revenues. The acquisition of Ambika Pathology further strengthens our Western Maharashtra cluster and supports our ambition to make high-quality diagnostics accessible to more communities,” said Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare.
“Kolhapur is an important healthcare hub, and the integration of Ambika Pathology Laboratory provides a formidable base to serve patients and clinicians more comprehensively. Ambika’s facility will be developed into a mini regional reference lab, strengthening our specialised diagnostics capabilities in the region,” said Surendran Chemmenkotil, Managing Director, Metropolis Healthcare.
Dr Rajendra Patil, Founder, Ambika Pathology Laboratory, said the collaboration would widen the scope of specialised tests available in Kolhapur and create new opportunities for medical professionals and patients to benefit from advanced diagnostic innovations.